Global Glycomics/Glycobiology Market to Reach $3.5 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Glycomics / Glycobiology: Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

Global Glycomics / Glycobiology Market to Reach $3.5 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Glycomics / Glycobiology is estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 16.7% over the analysis period 2020-2027. Enzymes, one of the segments analyzed in the report, is projected to record a 17.7% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Kits & Reagents segment is readjusted to a revised 16.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $351.3 Million, While China is Forecast to Grow at 16.1% CAGR

The Glycomics / Glycobiology market in the U.S. is estimated at US$351.3 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$604.3 Million by the year 2027 trailing a CAGR of 16.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.9% and 14.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.2% CAGR.

Instruments Segment to Record 15.1% CAGR

In the global Instruments segment, USA, Canada, Japan, China and Europe will drive the 15.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$241.4 Million in the year 2020 will reach a projected size of US$640.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 152 Featured) -

• Agilent Technologies, Inc.
• Bruker Corporation
• Danaher Corporation
• Merck KgaA
• New England Biolabs, Inc.
• Prozyme, Inc.
• Shimadzu Corporation
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.
• Waters Corporation

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• Glycomics/Glycobiology - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

UNITED STATES

• Glycomics / Glycobiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

• Glycomics / Glycobiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

• Glycomics / Glycobiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

• Glycomics / Glycobiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

• Glycomics / Glycobiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

• Glycomics / Glycobiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

• Glycomics / Glycobiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

REST OF EUROPE

ASIA-PACIFIC

• Glycomics / Glycobiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

REST OF WORLD

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/w53zfh